LUCÍA GALÁN DÁVILA-rekin lankidetzan egindako argitalpenak (17)

2022

  1. Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement

    Frontiers in Immunology, Vol. 13

  2. Cell therapy as a treatment strategy in amyotrophic lateral sclerosis

    Neurology Perspectives, Vol. 2, pp. S69-S73

2019

  1. Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer’s disease: clinical assessment and metabolic correlates

    Brain Imaging and Behavior, Vol. 13, Núm. 3, pp. 651-659

2017

  1. Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain niches

    BMC Neurology, Vol. 17, Núm. 1

  2. Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis and sample size

    Acta Neurologica Scandinavica

2014

  1. Cambios celulares producidos por la citotoxicidad del líquido cefalorraquídeo de pacientes con esclerosis lateral amiotrófica sobre cultivos de neuronas motoras

    Neurologia, Vol. 29, Núm. 6, pp. 346-352

  2. The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole

    Neurodegenerative Diseases, Vol. 13, Núm. 2-3, pp. 171-179

2012

  1. Mutación SOD1-N19S en una familia de esclerosis lateral amiotrófica

    Neurologia, Vol. 27, Núm. 1, pp. 11-15

2011

  1. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: Protection by resveratrol but not riluzole

    Brain Research, Vol. 1423, pp. 77-86

  2. Subventricular zone in motor neuron disease with frontotemporal dementia

    Neuroscience Letters, Vol. 499, Núm. 1, pp. 9-13

2010

  1. Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis

    Neurologia

  2. Terapia celular en la esclerosis lateral amiotrófica: Ciencia y controversia

    Neurologia, Vol. 25, Núm. 8, pp. 467-469

2009

  1. Análisis de la interconsulta hospitalaria a neurología en un hospital de tercer nivel

    Neurologia, Vol. 24, Núm. 10, pp. 835-840

2008

  1. Epidemiología analítica de la esclerosis lateral amiotrófica

    Neurologia, Vol. 23, Núm. 3, pp. 168-178

  2. Superoxide dismutase: The cause of all amyotrophic lateral sclerosis?

    Annals of Neurology

  3. Terapia celular en la esclerosis lateral amiotrófica

    Neurologia, Vol. 23, Núm. 4, pp. 226-237

2007

  1. Epidemiología descriptiva de la esclerosis lateral amiotrófica

    Neurologia, Vol. 22, Núm. 6, pp. 368-380